Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.5350 (-1.56%) ($8.5350 - $8.5350) on Mon. Apr. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.06% (three month average) | RSI | 64 | Latest Price | $8.5350(-1.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(31%) CEMB(25%) XLRE(24%) BND(22%) BWX(21%) | Factors Impacting BCRX price | BCRX will decline at least -1.53% in a week (0% probabilities). VIXM(-20%) VXX(-18%) UUP(-12%) TLT(-9%) VCIT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.53% (StdDev 3.06%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.47(0.77%) | 10 Day Moving Average | $8.48(0.65%) | 20 Day Moving Average | $8.36(2.09%) | To recent high | -23.2% | To recent low | 7.6% | Market Cap | $1.506b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |